NovoCure Limited

NovoCure Limited

NovoCure Limited is a medical device company focused on treating cancer with its cancer therapy device.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying NovoCure's stock with a target price of $37, indicating strong potential growth.

Above Average

Financial Health

NovoCure is performing well with strong revenue and cash flow, indicating solid business health.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring NVCR

Alternative Cancer Therapies Focus Shifts 2025

Alternative Cancer Therapies Focus Shifts 2025

The FDA's new boxed warning for Johnson & Johnson and Legend Biotech's cancer drug highlights potential safety issues in CAR-T therapies. This could shift focus to companies developing alternative and potentially safer oncology treatments.

Published: October 13, 2025

Explore Basket
Cancer Drug Safety: Could Warnings Create Opportunities?

Cancer Drug Safety: Could Warnings Create Opportunities?

The FDA's decision to add its strongest safety warning to a key cancer therapy from Johnson & Johnson and Legend Biotech underscores the inherent risks of powerful new treatments. This regulatory action could boost companies developing safer alternative cancer therapies, creating a new investment opportunity in the biotech sector.

Published: October 11, 2025

Explore Basket

Why You’ll Want to Watch This Stock

⚑

Tumour Treating Fields

A differentiated technology targeting cell division that investors watch for clinical proof points, though trial outcomes can be binary and affect valuation.

πŸ“ˆ

Commercial Expansion

Revenue potential rests on wider adoption, geographic rollout and payer coverage; execution risk and reimbursement delays may temper near‑term growth.

🌍

Regulatory & Reimbursement

Approval decisions and payer policies shape market access; positive decisions can boost uptake, while unfavourable rulings can limit growth.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions